PREVENTION OF CARDIOVASCULAR DISEASES (CVD)
|
|
- Alexia Watkins
- 6 years ago
- Views:
Transcription
1 PREVENTION OF CARDIOVASCULAR DISEASES (CVD)
2 SIGNIFICANCE OF NON-COMMUNICABLE DISEASES Non-communicable diseases were responsible for 2/3 of all deathsglobally in 2011, up from 60% in High-income countries have the highest proportion 87% of all deaths were caused by NCDs followed by upper-middle income countries (81%). Cardiovascular diseases alone killed nearly 2 million more people in 2011 than in the year CVDsremainthemajor cause of premature death in Europe, It is estimated that >80% of all CVD mortality nowoccursin developing countries.
3
4
5 CVD causes mass disability: SIGNIFICANCE OF CVDs within the coming decades thedisability-adjusted life years (DALYs) estimate is expected to risefrom a loss of 85 million DALYs in 1990 to a loss of 150million DALYsglobally in 2020, remaining the leadingsomatic cause of loss of productivity.
6 Burdenof disease DALY DALYs = Disability Adjusted Life Years The sum of years of potential life lost due to prematuremortality and the years of productive life lost due to disability. DALY measures: deaths at different ages disability 1DALY=one lost year of healthy life. Burdenof disease = measurement of the gap between current health status and an ideal situation where everyone lives into old age, free of disease and disability.
7 TYPES OF CVD Ischemic originated Cerebrovascular originated Peripheral vascular diseases Infectious originated diseases Heart insufficiencies Cardiomyopathies Congenital heart diseases
8
9 SIGNIFICANCE OF CVDs CVD is strongly connected to lifestyle, tobacco, unhealthy diet habits, physical inactivity, and psychosocialstress. The (WHO) has stated that: over three-quarters of all CVD mortality may be preventedwithadequate changes in lifestyle. CVD prevention majorchallenge for the general population, politicians, and healthcareworkers, defined as a coordinated set of actions, at public and individual level, The basesof prevention are rooted in cardiovascular epidemiology and evidence-based medicine.
10 Levelof evidence
11 Whyis preventionof CVDsneeded? Atherosclerotic CVD, especially CHD, remains the leading cause of premature death worldwide. CVD affectsboth men and women; of all deaths that occurbefore the age of 75 years in Europe, 42% are due to CVD inwomen and 38% in men. CVD mortality is changing, with declining age-standardized ratesin most European countries, which remain high in Eastern Europe. Prevention works: >50% of the reductions seen in CHD mortalityrelate to changes in risk factors, and 40% to improved treatments. Preventive efforts should be lifelong, from birth (if not before) to old age. Population and high-risk preventive strategies should be complementary;an approach limited to high-risk persons will be less effective; population education programmes are still needed. Despitegaps in our understanding, there is evidencetojustify intensive public health and individual preventive efforts. There is still substantial room for improvement in risk factorcontrol, even in individuals at very high risk.
12 Cardiovascularrisk The likelihood of a person developing an atherosclerotic cardiovascular event over a defined time period. Howtoadviseyoungerpersons at low absolute but high relative risk? Cliniciansoften ask for threshold values at which totrigger an intervention, this is problematic since risk is a continuumand there is no exact point above which, for example, a drug isautomatically indicated, nor below which lifestyle advice may notusefullybe offered. Total risk: an estimate of risk made by considering theeffect of the major factors: age, gender, smoking, BP, and lipid levels.
13 Relationship between total cholesterol/hdl cholesterol ratio and 10-year fatal CVD events in men and women aged 60 years with and without risk factors
14 Riskestimation It is recommended that risk factorscreening including the lipid profile may be considered in adultmen >40 years old and in women >50 years of age orpost-menopausal. Total risk assessment be offered during a consultation if: The person asks for it. One or more risk factors such as smoking, overweight, or hyperlipidaemia are known. There is a family history of premature CVD or of major riskfactorssuchas hyperlipidaemia. There are symptoms suggestive of CVD. The SCORE system estimates the 10-year risk of a first fatal atherosclerotic event, whether heart attack, stroke, aneurysm of the aorta, or other.
15 High CVD risk SCORE chart: 10-year risk of fatal cardiovascular disease (CVD) in countries at Low CVD risk
16 SCORE charts
17
18 Riskfactors Non-modifiable Age Gender Genetics Modifiable Smoking Unhealthy nutrition Lack of physical activity Overweight, obesity Alcohol Other diseases Psychosocial factors Biomarkers
19 Riskfactors Non-modifiable Genetics heritability of many cardiovascular risk factors. Familial prevalence of atherosclerotic disease or of major riskfactors (high BP, diabetes mellitus, hyperlipidaemia) should be systematically sought in the first-degree relatives of any patientaffected before 55 years in men and 65 years in women. Ageand gender biggest cause of death in women. The lower rates of CHD in women but not of stroke may be interpreted as a protective effect of endogenous oestrogens.
20 Riskfactors Modifiable Psychosocial factors Low socio-economic status(low educational level, low income, holding a low-status job, or living in a poor residential area) lack of social support, stress atwork and in family life, depression, anxiety, hostility, type D personality(distressed)
21 Riskfactors Modifiable Biomarkers Inflammatory biomarkers: high-sensitivity CRP, homocystein Thrombotic biomarkers: fibrinogen, lipoprotein-associated phospholipase(lppla2) Other diseases with increased CVD risk Chronic kidney disease(hypertension, dyslipidaemia, DM) Obstructive sleep apnoea Autoimmune diseases(psoriasis, rheumatiod arthritis, SLE) Periodontitis
22 Preventionof CVDs
23 Transtheoretical model of behavior change(stages of changes) CVD Prevention Evidence has confirmed cognitivebehaviouralstrategies to beessential components of interventions targeting lifestyle change. Individualsof lowses, of older age, or female gender may need tailored programmesin order to meet their specific needs regarding informationand emotional support.
24 Smoking cessation Minimal Intervention 5As
25 Healthy nutrition
26 Physicalactivity Intensity and volume moderate-intensity physical activity or aerobic exercisetraining from 2.5 to 5 h/week; vigorous-intensity physical activity/aerobic exercise training1 1.5 h/week not only sport-related activities, but also lifestyle-commonactivities(walking briskly, climbing stairs, doing more housework andgardening work, and engaging in active recreational pursuits).
27 Body weight
28 Body weight The WHO thresholds for waist circumference accepted in Europe: Action level 1 waist circumference 94 cm in men and 80 cm in women represents no further weight should be gained. Action level 2 waist circumference 102 cm in men and 88 cm in women represents weight reduction should be advised.
29 Highbloodpressure
30 High Blood Pressure management Source: 2003 ESH/ESC Hypertension Guidelines. Journal of Hypertension 2003, Vol 21 No 10. DASH diet (Dietary Approaches to Stop Hypertension)
31 Preventionstrategies Weight reduction in overweight and obese people is recommended as this is associated withfavourableeffects on blood pressure and dyslipidaemia, which may lead to less CVD. Healthy adults of all ages have to spend hours a week on physical activity of at leastmoderate intensity, or hours a week on vigorous intense exercise. Sedentary subjects shouldbe strongly encouraged to start light-intensity exercise programmes. Patients with previous CVDsshould undergo moderate-to-vigorous intensity aerobic exercise training 3 times a week and 30 min per session. Multimodal behaviouralinterventions, integrating health education, physical exercise andpsychological therapy for psychosocial risk factors and coping with illness, should be prescribed.
32 Managingriskfactors Lifestyle measures such as weight control, increased physical activity, alcohol moderation,sodium restriction, and increased consumption of fruits, vegetables, and low-fat dairy productsare recommended in all patients with hypertension and in individuals with high normal blood pressure. All major antihypertensive drug classes(i.e. diuretics, ACE inhibitors, calcium antagonists, angiotensinreceptor antagonists and beta-blockers) do not differ significantly in their bloodpressure-lowering efficacy and thus should be recommended for the initiation and maintenance of antihypertensive treatment. In patients with grade 1 or 2 hypertension and at moderate total cardiovascular risk, drugtreatment may be delayed for several weeks, and in grade 1 hypertensive patients without anyother risk factor, for several months while trying lifestyle measures. Drug treatment is recommended to be initiated promptly in patients with grade 3 hypertension,as well as in patients with grade 1 or 2 hypertension who are at high or very high total cardiovascular risk. Systolic blood pressure should be lowered to <140 mmhg (and diastolic blood pressure <90 mmhg) in all hypertensive patients.
33 Managingriskfactors The target HbA1c for the prevention of CVD in diabetes of <7.0% (<53 mmol/mol) is recommended. In patients at very high CVD risk, the recommended LDL cholesterol target is <1.8 mmol/l(<~70 mg/dl) or a 50% LDL-cholesterol reduction when the target level cannot be reached. In patients at high CVD risk, a LDL-cholesterol goal <2.5 mmol/l (<~100 mg/dl) is recommended. The recommended target levels are <5 mmol/l (<~190 mg/dl) for total plasma cholesterol and <3 mmol/l (<~115 mg/dl) for LDL cholesterol for subjects at low or moderate risk.
34 Secondarypreventionof CVD Blood pressure measurement Anthropometric meausrements Ankle-brachialBP index (ABI < 0.9 PAD) Ophthalmoscopy (Exercise ECG Carotid ultrasound Echocardiography Radionuclide scintigraphy)
35 Ankle/brachialindex (ABI) An ABI <0.9 indicates 50% stenosis between the aorta andthedistalleg arteries. Over 50 % stenosis: sensitivity ~90% specificity ~98% Hiatt WR. N Engl J Med. 2001;344(21):
36 Where should CVD prevention be offered? Actions to prevent CVD should be incorporated into everyone s daily lives, starting in early childhood and continuing throughout adulthood and senescence. Risk factor screening including the lipid profile may be considered in adult men 40 years oldand in women 50 years of age or postmenopausal. The physician in general practice is the key person to initiate, coordinate and provide longterm follow-up for CVD prevention. Nurse-coordinated prevention programmes should be well integrated into healthcare systems. The practisingcardiologistshould be the advisor if there is uncertainty over the use of preventive medication or when usual preventive options are difficult to apply. All patients with CVD must be discharged from hospital with clear guideline-orientated treatment recommendations to minimize adverse events. All patients requiring hospitalization or invasive intervention after an acute coronary syndromeshould participate in a cardiac rehabilitation programmeto improve prognosis by modifying lifestyle habits and increasing treatment adherence. Non-governmental organisationsare important partners to health care workers in promoting preventive cardiology.
37 PerkJ. et al.: European Guidelines on cardiovascular diseasepreventioninclinicalpractice(version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in ClinicalPractice (constituted by representatives of nine societiesand byinvitedexperts). European Heart Journal (2012) 33,
Five chapters 1. What is CVD prevention 2. Why is CVD prevention needed 3. Who needs CVD prevention 4. How is CVD prevention applied 5. Where should CVD prevention be offered Shorter, more adapted to clinical
More information2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE
2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE Massimo F Piepoli, MD, PhD, FESC, Piacenza, Italy on behalf of the 6 th Joint Task Force 2 3 Guidelines still based upon the principles of
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationClasses of recommendations
Classes of recommendations Levels of evidence Quality of evidence used in GRADE Percentage of the decrease in deaths from coronary heart disease attributed to treatments and risk factor changes in different
More informationAppendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular
More informationSecondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION
Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationRisk Factors for NCDs
Risk Factors for NCDs Objectives: Define selected risk factors such as; tobacco use, diet, nutrition, physical activity, obesity, and overweight Present the epidemiology and significance of the risk factors
More informationPREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN
1980 to 2000: Death rate fell from: 542.9 to 266.8 per 100K men 263.3 to 134.4 per 100K women 341,745 fewer deaths from CHD in 2000 Ford ES, NEJM, 2007 47% from CHD treatments, 44% from risk factor modification
More information2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary
2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth
More informationSession 21: Heart Health
Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk
More informationHeart Disease and Stroke in New Mexico. Facts and Figures: At-A-Glance
Heart Disease and Stroke in New Mexico Facts and Figures: At-A-Glance December H e a r t D i s e a s e a n d S t r o k e Heart disease and stroke are the two most common conditions that fall under the
More informationYour Name & Phone Number Here! Longevity Index
Your Name & Phone Number Here! Longevity Index Your Health Risk Analysis is based on a variety of medical and scientific data from organizations such as the American Heart Association, American Dietetic
More informationNon communicable Diseases in Egypt and North Africa
Non communicable Diseases in Egypt and North Africa Diaa Marzouk Prof. Community Medicine Faculty of Medicine, Ain Shams University Egypt 11 th March 2012 Level of Income North African countries according
More informationASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
More informationSIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence
SIGN 149 Risk estimation and the prevention of cardiovascular disease Quick Reference Guide July 2017 Evidence ESTIMATING CARDIOVASCULAR RISK R Individuals with the following risk factors should be considered
More informationNational Strategy. for Control and Prevention of Non - communicable Diseases in Kingdom of Bahrain
Kingdom of Bahrain Ministry of Health National Strategy for Control and Prevention of Non - communicable Diseases in Kingdom of Bahrain 2014 2025 Behavioural Risk Factors Tobacco Use Unhealthy Diets Physical
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationREPORT FROM THE CANADIAN CHRONIC DISEASE SURVEILLANCE SYSTEM:
REPORT FROM THE CANADIAN CHRONIC DISEASE SURVEILLANCE SYSTEM: PROTECTING AND EMPOWERING CANADIANS TO IMPROVE THEIR HEALTH TO PROMOTE AND PROTECT THE HEALTH OF CANADIANS THROUGH LEADERSHIP, PARTNERSHIP,
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationClinical Recommendations: Patients with Periodontitis
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;
More informationClinical Care Performance. Financial Year 2012 to 2018
Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c
More informationGuidelines for Integrated Management of. Cardiovascular Diseases and Diabetes. in Clinics and Ri-hospitals
Guidelines for Integrated Management of Cardiovascular Diseases and Diabetes in Clinics and Ri-hospitals Ministry of Public Health DPR Korea January 2013 Rationale ncommunicable diseases such as cardiovascular
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationBlood Pressure Acre Surgery Diviash Thakrar
Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise
More informationEuroPrevent 2010 Fatal versus total events in risk assessment models
EuroPrevent 2010 Fatal versus total events in risk assessment models Pekka Jousilahti, MD, PhD,Research Professor National Institute for Health and Welfare, Finland Risk assessment models Estimates the
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationPrimary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group
Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationSECONDARY HYPERTENSION
HYPERTENSION Hypertension is the clinical term used to describe a high blood pressure of 140/90 mmhg or higher (National Institute of Health 1997). It is such a health risk the World Health Organisation
More informationExecutive Summary Report Sample Executive Report Page 1
Sample Executive Report Page 1 Introduction This report summarizes the primary health findings for those individuals who completed the Personal Wellness Profile (PWP) health assessment. Group health needs
More informationDefinition High Blood Pressure is a
May 10th 2014 Definition High Blood Pressure is a common condition in which the force of the blood against your artery walls is high enough that it may eventually cause health problems, such as heart disease.
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationChapter 18. Diet and Health
Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in
More informationUpdate on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease
More informationFaculty of Medicine. Lecture 17 The global health impact of Cardiovascular Diseases, Diabetes and Obesity. Hatim Jaber MD MPH JBCM PhD
Faculty of Medicine الصحة العامة (31505291) Health Public Lecture 17 The global health impact of Cardiovascular Diseases, Diabetes and Obesity By Hatim Jaber MD MPH JBCM PhD 30-7-2018 1 1. The global health
More information1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)
I. TEST YOUR KNOWLEDGE OF CHOLESTEROL Choose the correct answer. 1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) 2. Only
More informationHeart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system
LEARN Learn about HTHU Level 3 and the point system 01 IDENTIFY Identify the major risk factors for cardiovascular disease and how to improve our cardiovascular health 03 02 ACT Begin our Session 1 Goal
More informationPRESENTED BY BECKY BLAAUW OCT 2011
PRESENTED BY BECKY BLAAUW OCT 2011 Introduction In 1990 top 5 causes of death and disease around the world: Lower Respiratory Tract Infections Diarrhea Conditions arising during pregnancy Major Depression
More informationFaculty of Medicine. Lecture 16 The global health impact of Cardiovascular Diseases, Diabetes and Obesity. Hatim Jaber MD MPH JBCM PhD
Faculty of Medicine الصحة العامة (31505291) Health Public Lecture 16 The global health impact of Cardiovascular Diseases, Diabetes and Obesity By Hatim Jaber MD MPH JBCM PhD 12-7-2017 1 1. The global health
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationCardiovascular Complications in Diabetes
What is all the fuss about? Cardiovascular Complications in Diabetes Dina Shrestha MD Consultant Endocrinologist Norvic International Hospital and Medical College Hospital for Advanced Medicine and Surgery
More informationCardiovascular Disease
Cardiovascular Disease Chapter 15 Introduction Cardiovascular disease (CVD) is the leading cause of death in the U.S. One American dies from CVD every 33 seconds Nearly half of all Americans will die from
More informationStrokes , The Patient Education Institute, Inc. hp Last reviewed: 11/11/2017 1
Strokes Introduction A stroke or a brain attack is a very serious condition that can result in death and significant disability. This disease is ranked as the third leading cause of death in the United
More informationWhat is hypertension?
HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90
More informationThe importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher
The importance of follow-up after a cardiac event: CARDIAC REHABILITATION Dr. Guy Letcher The National Medicare Experience Mortality After Angioplasty 225,915 patients Mortality After Bypass Surgery 357,885
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationCardiovascular Disease Risk Factors:
Cardiovascular Disease Risk Factors: Risk factors are traits or habits that increase a person's chances of having cardiovascular disease. Some risk factors can be changed. These risk factors are high blood
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationPrevalence of Cardiac Risk Factors among People Attending an Exhibition
IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 3, Issue 6 Ver. IV (Nov.-Dec. 2014), PP 4-51 Prevalence of Cardiac Risk Factors among People Attending
More informationThe Battle against Non-communicable Diseases can be won IA.. Lidia Belkis Archbold Health Ministries - IAD
The Battle against Non-communicable Diseases can be won IA.. Lidia Belkis Archbold Health Ministries - IAD Non-communicable diseases (NCDs), also known as chronic diseases are not transmitted from person
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationAPPENDIX 2F Management of Cholesterol
Patients with established CVD: Coronary heart disease Cerebrovascular disease Peripheral vascular disease APPEDIX 2F Management of Cholesterol Patients at high risk of cardiovascular events: Chronic kidney
More informationCLINICAL OUTCOME Vs SURROGATE MARKER
CLINICAL OUTCOME Vs SURROGATE MARKER Statin Real Experience Dr. Mostafa Sherif Senior Medical Manager Pfizer Egypt & Sudan Objective Difference between Clinical outcome and surrogate marker Proper Clinical
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationPage down (pdf converstion error)
1 of 6 2/10/2005 7:57 PM Weekly August6, 1999 / 48(30);649-656 2 of 6 2/10/2005 7:57 PM Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999
More informationStandards of Medical Care in Diabetes 2016
Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking
More informationHeart Disease. Signs and Symptoms
Heart Disease The term "heart disease" refers to several types of heart conditions. The most common type is coronary artery disease, which can cause heart attack, angina, heart failure, and arrhythmias.
More informationHeart Disease Risk Factors
Heart Disease Risk Factors High Blood Cholesterol and High Triglyceride Levels Cholesterol High blood cholesterol is a condition in which there's too much cholesterol a waxy, fat-like substance in your
More informationX-Plain Essential Hypertension Reference Summary
X-Plain Essential Hypertension Reference Summary Introduction Hypertension, or high blood pressure, is a very common condition that affects 1 out of every 4 adults. Hypertension is also called the silent
More informationSteps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life Your Guide to Ischemic What Happened to Me? You had a stroke. The stroke you had
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationTHE NEW HEALTH PROGRAMME
LET S ACT TOGETHER TO PREVENT CARDIOVASCULAR DISEASES THE NEW HEALTH PROGRAMME MARKETING & SERVICES AFRICA HEALTH AT THE HEART OF OUR CONCERNS Health plays a vital role in a country s economic and social
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationUnderstanding Cholesterol and Triglycerides
MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Understanding Cholesterol and Triglycerides About This Kit Along with cigarette smoking, high blood pressure, physical
More informationCardiovascular System and Health. Chapter 15
Cardiovascular System and Health Chapter 15 Cardiovascular Disease Leading cause of death in U.S. Claims 1 life every 43 seconds Often, the first sign is a fatal heart attack Death Rates #1 CVD #2 Cancer
More informationDYSLIPIDEMIA RECOMMENDATIONS
DYSLIPIDEMIA RECOMMENDATIONS Α. DIAGNOSIS Recommendation 1 INITIAL LIPID PROFILING (Level of evidence II) It is recommended to GPs and other PHC Physicians to assess the lipid profile {total cholesterol
More informationTennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center
Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center 2006 Tennessee Department of Health 2006 ACKNOWLEDGEMENTS CONTRIBUTING
More informationFrequently asked questions in response to ABC Catalyst report about cholesterol and medications
Frequently asked questions in response to ABC Catalyst report about cholesterol and medications Quick links to the evidence available: The Heart Foundation s guideline for the management of primary prevention
More informationHYPERTENSION: ARE WE GOING TOO LOW?
HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA
More informationBEST PRACTICE MANAGEMENT: CARDIOVASCULAR RISKS
BEST PRACTICE MANAGEMENT: CARDIOVASCULAR RISKS Neil R Poulter ICCH, Imperial College London BHIVA: October 10th, 2008 Background CVD is the biggest single killer in the world CVD rates are increasing High
More informationNew indicators to be added to the NICE menu for the QOF and amendments to existing indicators
New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.
More informationDyslipidemia in women: Who should be treated and how?
Dyslipidemia in women: Who should be treated and how? Lale Tokgozoglu, MD, FACC, FESC Professor of Cardiology Hacettepe University Faculty of Medicine Ankara, Turkey. Cause of Death in Women: European
More informationDyslipidemia in the light of Current Guidelines - Do we change our Practice?
Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease
More informationHypertension Guidelines 2017
Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,
More informationProof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government
Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...
More information4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for
+ Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationFrom the desk of the: THE VIRTUAL NEPHROLOGIST
Hypertension, also referred to as high blood pressure or HTN, is a medical condition in which the blood pressure is chronically elevated. It is a very common illness. One out of three American adults has
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationmajor public health burden
HYPERTENSION INTRODUCTION Hypertension is one of the major public health burden in the recent times. Hypertension remains a challenging medical condition among the noncommunicable diseases of ever growing
More informationCoronary heart disease statistics edition. Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner
Coronary heart disease statistics 2007 edition Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner Health Promotion Research Group Department of Public Health, University of Oxford
More informationPrevenzione cardiovascolare e cambiamento degli stili di vita. Gian Franco Gensini
Prevenzione cardiovascolare e cambiamento degli stili di vita Gian Franco Gensini Main causes of death worldwide at all ages (year:: 2005) 17.5 milion Preventing Chronic Diseases A vital investiment. WHO
More informationNew Guidelines in Dyslipidemia Management
The Fourth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 2018 New Guidelines in Dyslipidemia Management Dr. Khalid Al-Waili, MD, FRCPC, DABCL Senior Consultant Medical
More informationHeart disease in Women
Heart disease in Women Extent and risk assessment Charles McCreery MB FACC St Vincent's Hospital Dublin St Columcille s Hospital Dublin Natural Progression of Atherosclerosis Heart disease risk differs
More informationPatients First. Risk Reduction for Heart and Vascular Disease. High blood cholesterol is one of the major risk factors for heart and vascular disease.
Patient Education HEALTH AND WELLNESS High blood cholesterol is one of the major risk factors for heart and vascular disease. Risk Reduction for Heart and Vascular Disease Risk factors are habits, traits
More informationEUROACTION. A European Society of Cardiology Demonstration Project in Preventive Cardiology FINAL RESULTS
EUROACTION A European Society of Cardiology Demonstration Project in Preventive Cardiology FINAL RESULTS Professor David Wood on behalf of the EUROACTION Group EUROACTION 8 countries 24 centres 962 subjects
More informationCardiovascular Risk Factors: Distribution and Prevalence in a Rural Population of Bangladesh
"Insight Heart" is also available at www.squarepharma.com.bd Cardiovascular Risk Factors: Distribution and Prevalence in a Rural Population of Bangladesh Coronary heart disease has been emerging as an
More informationCardiovascular Disease in Women -Vive La Difference? Dr Homeyra Douglas Consultant Cardiologist Aintree University Hospital
Cardiovascular Disease in Women -Vive La Difference? Dr Homeyra Douglas Consultant Cardiologist Aintree University Hospital Death By Cause - Women 2004 UK Death by Cause-Women 2004 UK -CVD is responsible
More informationHealthPartners Care Coordination Clinical Care Planning and Resource Guide HYPERTENSION
The following evidence based guideline was used in developing this clinical care guide: National Institute of Health (NIH) and Journal of the American Medical Association (JAMA). Documented Health Condition:
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More informationDisclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2014 AAHP Fall Seminar Sherry Myatt, PharmD, BCPS Assistant Director of Pharmacy for
More informationEvidenceNOW SW Learning Collaborative. Kyle Knierim, MD January 2017
EvidenceNOW SW Learning Collaborative Kyle Knierim, MD January 2017 What is cardiovascular disease? Why are we even talking about cardiovascular disease? What can we do to prevent and treat cardiovascular
More informationCoronary Artery Disease Clinical Practice Guidelines
Coronary Artery Disease Clinical Practice Guidelines Guidelines are systematically developed statements to assist patients and providers in choosing appropriate healthcare for specific clinical conditions.
More informationUnit 4: Contemporary Nutrition Issues. Good Health and Malnutrition (Overnutrition)
Unit 4: Contemporary Nutrition Issues Good Health and Malnutrition (Overnutrition) Introduction to Contemporary Nutrition Issues The decisions people make have social, economic, health and environmental
More informationCARDIOVASCULAR HEALTH
CARDIOVASCULAR HEALTH CONTROLLING YOUR RISK FACTORS Carina Price, RN, COHC Heart Disease The Facts Heart Disease Heart Disease is more common than decades in the past and often silent until it strikes.
More information